Tech
Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A (Patricia Allen/EU-Startups)
Patricia Allen / EU-Startups:
Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics and AI algorithms, has raised €30 million in Series A fundingPharmatech startup Aqemia has just raised 30 million euros in a new round of funding. The Paris-based startup is creating a pioneering drug discovery pipeline…
